Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BTMD |
---|---|---|
09:32 ET | 592 | 5.08 |
09:34 ET | 500 | 5.05 |
09:36 ET | 400 | 5.05 |
09:38 ET | 100 | 5.01 |
09:41 ET | 100 | 5.11 |
09:43 ET | 364 | 5.05 |
09:45 ET | 200 | 5.04 |
09:50 ET | 200 | 5.05 |
09:57 ET | 239 | 4.985 |
10:01 ET | 200 | 4.99 |
10:03 ET | 100 | 4.9783 |
10:08 ET | 2986 | 4.96 |
10:12 ET | 100 | 4.95 |
10:14 ET | 1003 | 4.975 |
10:15 ET | 200 | 4.98 |
10:19 ET | 300 | 4.975 |
10:21 ET | 112 | 4.97 |
10:24 ET | 500 | 4.96 |
10:26 ET | 2580 | 4.96 |
10:28 ET | 600 | 4.965 |
10:30 ET | 100 | 4.96 |
10:32 ET | 160 | 4.95 |
10:33 ET | 1582 | 4.96 |
10:37 ET | 2110 | 4.96 |
10:39 ET | 2460 | 4.94 |
10:42 ET | 13164 | 4.96 |
10:44 ET | 870 | 4.98 |
10:46 ET | 200 | 5.04 |
10:51 ET | 992 | 5.015 |
10:53 ET | 992 | 5.0367 |
10:55 ET | 400 | 5.07 |
10:57 ET | 1944 | 5.06 |
11:04 ET | 100 | 5.06 |
11:08 ET | 200 | 5.065 |
11:09 ET | 1594 | 5.07 |
11:15 ET | 100 | 5.085 |
11:20 ET | 100 | 5.09 |
11:22 ET | 100 | 5.09 |
11:24 ET | 1290 | 5.06 |
11:26 ET | 819 | 5.065 |
11:29 ET | 175 | 5.065 |
11:33 ET | 220 | 5.06 |
11:38 ET | 3767 | 5.05 |
11:40 ET | 2250 | 5.055 |
11:42 ET | 3582 | 5.045 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biote Corp | 271.1M | 23.1x | --- |
Kewaunee Scientific Corp | 89.1M | 5.1x | +61.89% |
Performant Financial Corp | 268.6M | -41.9x | --- |
MariMed Inc | 59.3M | -3.3x | --- |
National Research Corp | 483.4M | 16.8x | +3.30% |
Cass Information Systems Inc | 543.8M | 20.3x | +1.45% |
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $271.1M |
---|---|
Revenue (TTM) | $187.2M |
Shares Outstanding | 54.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $0.22 |
Book Value | $-0.86 |
P/E Ratio | 23.1x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | 14.5x |
Operating Margin | 15.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.